TCS life sciences advisory services
Offering actionable insights across the life sciences value chain
2
MINS READ
Industry
Life Sciences
Patient-centered Care Models Taking Center Stage in Life Sciences
Highlights
- Healthcare professionals and patients demand better value outcomes, higher levels of information access, and transparency.
- This increased focus on patient experiences and emergence of new market players are just a few of the factors that are causing a paradigm shift in the life sciences industry.
- TCS Life Sciences Advisory services enables professionals from pharmaceutical, medical technology, and biologics companies to evaluate their imperatives and define forward-looking strategies, to achieve superior business outcomes.
In this article
Overview
Within a decade, life sciences companies are witnessing a sea change in their business environment.
The growth of personalized medicine, shifting manufacturing paradigms, rapidly evolving regulatory environment, increased focus on patient outcomes, and emergence of new market players along with advances in information technology call for a change of strategy and operations, to maintain business advantage.
Challenge
A number of disrupting factors are causing this paradigm shift in the life sciences industry.
Growth in areas such as translational research and genomics is pushing medicine toward personalization. Government regulations have resulted in increased operational mandates and a downward pressure on margins.
Our solution
Healthcare professionals and patients demand better value outcomes, higher levels of information access, and transparency.
Convergence of processes, data, and science have led life sciences companies to rethink their digital transformation strategies.
TCS Life Sciences Advisory services help executives in pharmaceutical, medical technology, and biologics companies to evaluate their imperatives, define forward-looking strategies, and tailor them into actionable plans for rapid execution. Our Advisory services span the entire spectrum of life sciences value chain. These comprise:
Clinical and research advisory - to Optimizing clinical trials management, patient engagement, and cure pathways
Supply chain management advisory - Focusing on strategy and execution to enable agile and responsive supply chains
Manufacturing advisory – Helping companies with strategy and execution to enable digital manufacturing
Engineering advisory - Enabling efficient new product introduction for medical devices and diagnostic equipments
Laboratory advisory - Generating process and systems roadmap to streamline laboratory operations
Sales and marketing advisory - Improving clients’ customer intimacy and operational efficiency by delivering high impact digital capabilities across the customer value chain
Regulatory advisory and assessment - Optimizing end-to-end regulatory processes and activities, combined with our capabilities in regulatory operations to deliver solutions for life cycle maintenance
M&A advisory services - Delivering all aspects of a company’s integration or divestiture, from the initial strategy and planning phase through execution and operation
Compliance and validation services - Improving adherence to various regulatory requirements and standards like GAMP (good automated manufacturing practice), ICH (International council for harmonisation of technical requirements for pharmaceuticals for human use), ISO 13485, QSR (quality system requirements), and the like.
Benefits
Offering a complete set of digital transformation services and solutions
We work with life sciences companies to derive actionable insights, create exponential value, and achieve superior business outcomes. Benefits include:
Improved forecasting accuracy by 8 -12%
Improved inventory performance up to 50%
Reduced clinical trial cycle time by 10-25%
Improved patient adherence to trial protocols by 20-40%
Improved regulatory compliance, regulatory reporting cycle times by 10-25%
Improved productivity through effective scheduling and tracking of resources and tests by 5-15%
Increased customer service levels, working capital efficiency by 20-50%
Improved plant throughput, reduced manufacturing cycle times by 10-40%
